173 related articles for article (PubMed ID: 21336740)
1. Two cases of primary intraocular lymphoma: fine needle aspiration diagnosis and intravitreal methotrexate treatment.
Zhao T; Li Y; Tang L; Wei X; Zhu X
J Huazhong Univ Sci Technolog Med Sci; 2011 Feb; 31(1):142-144. PubMed ID: 21336740
[TBL] [Abstract][Full Text] [Related]
2. [A case of intraocular lymphoma having retinal adverse events associated with intravitreal methotrexate].
Kuroiwa N; Abematsu N; Matsuo Y; Nakao K; Sakamoto T
Nippon Ganka Gakkai Zasshi; 2011 Jul; 115(7):611-6. PubMed ID: 21815491
[TBL] [Abstract][Full Text] [Related]
3. Intravitreal methotrexate for treating vitreoretinal lymphoma: 10 years of experience.
Frenkel S; Hendler K; Siegal T; Shalom E; Pe'er J
Br J Ophthalmol; 2008 Mar; 92(3):383-8. PubMed ID: 18303160
[TBL] [Abstract][Full Text] [Related]
4. High-dose methotrexate following intravitreal methotrexate administration in preventing central nervous system involvement of primary intraocular lymphoma.
Akiyama H; Takase H; Kubo F; Miki T; Yamamoto M; Tomita M; Mochizuki M; Miura O; Arai A
Cancer Sci; 2016 Oct; 107(10):1458-1464. PubMed ID: 27412324
[TBL] [Abstract][Full Text] [Related]
5. An Asian patient with intraocular lymphoma treated by intravitreal methotrexate.
Wang JK; Yang CM; Lin CP; Shan YD; Lo AY; Tien HF
Jpn J Ophthalmol; 2006; 50(5):474-478. PubMed ID: 17013703
[TBL] [Abstract][Full Text] [Related]
6. A case of primary intraocular lymphoma treated by intravitreal methotrexate.
Kim E; Kim C; Lee J; Cho Y
Korean J Ophthalmol; 2009 Sep; 23(3):210-4. PubMed ID: 19794951
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcomes of primary intraocular lymphoma patients treated with front-line systemic high-dose methotrexate and intravitreal methotrexate injection.
Ma WL; Hou HA; Hsu YJ; Chen YK; Tang JL; Tsay W; Yeh PT; Yang CM; Lin CP; Tien HF
Ann Hematol; 2016 Mar; 95(4):593-601. PubMed ID: 26732884
[TBL] [Abstract][Full Text] [Related]
8. [Primary intraocular lymphoma invaded to the central nervous system after successful treatment with intraocular methotrexate injection].
Watanabe K; Arai A; Takase H; Takahashi H; Iwanaga Y; Sugamoto Y; Sugita S; Mochizuki M; Miura O
Rinsho Ketsueki; 2009 Mar; 50(3):182-6. PubMed ID: 19352085
[TBL] [Abstract][Full Text] [Related]
9. Local methotrexate and dexamethasone phosphate for the treatment of recurrent primary intraocular lymphoma.
Velez G; Boldt HC; Whitcup SM; Nussenblatt RB; Robinson MR
Ophthalmic Surg Lasers; 2002; 33(4):329-33. PubMed ID: 12134997
[TBL] [Abstract][Full Text] [Related]
10. Role of intravitreal methotrexate in the management of primary central nervous system lymphoma with ocular involvement.
Smith JR; Rosenbaum JT; Wilson DJ; Doolittle ND; Siegal T; Neuwelt EA; Pe'er J
Ophthalmology; 2002 Sep; 109(9):1709-16. PubMed ID: 12208721
[TBL] [Abstract][Full Text] [Related]
11. [Primary intraocular lymphoma].
Coupland SE; Heimann H
Ophthalmologe; 2004 Jan; 101(1):87-98. PubMed ID: 14986704
[TBL] [Abstract][Full Text] [Related]
12. [Initial experience of treatment of primary intraocular lymphomas associated with primary CNS lymphomas].
Tropinskaia OF; Grishina EE; Serova NK; Kobiakov GL; Aronov MS; Shishkina LV
Zh Vopr Neirokhir Im N N Burdenko; 2012; 76(4):19-25; discussion 25. PubMed ID: 23033588
[TBL] [Abstract][Full Text] [Related]
13. Intravitreal methotrexate as an adjunctive treatment of intraocular lymphoma.
Fishburne BC; Wilson DJ; Rosenbaum JT; Neuwelt EA
Arch Ophthalmol; 1997 Sep; 115(9):1152-6. PubMed ID: 9298056
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of intravitreal methotrexate to salvage eyes with relapsed primary intraocular lymphoma.
Mohammad M; Andrews RM; Plowman PN; Hay G; Arora AK; Cohen VML; Sagoo MS
Br J Ophthalmol; 2022 Jan; 106(1):135-140. PubMed ID: 33087316
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and toxicity of intravitreal chemotherapy for primary intraocular lymphoma.
Velez G; Yuan P; Sung C; Tansey G; Reed GF; Chan CC; Nussenblatt RB; Robinson MR
Arch Ophthalmol; 2001 Oct; 119(10):1518-24. PubMed ID: 11594954
[TBL] [Abstract][Full Text] [Related]
16. Reduced frequency of Intravitreal methotrexate injection lowers the risk of Keratopathy in Vitreoretinal lymphoma patients.
Zhou X; Zhou X; Shi H; Lai J; Wang Q; Li Y; Chen K; Li Q; Zhou Q; Cao X; Chen B; Xiao J
BMC Ophthalmol; 2020 May; 20(1):189. PubMed ID: 32397978
[TBL] [Abstract][Full Text] [Related]
17. [Malignant lymphoma of the central nervous system and eye].
Tropinskaia OF; Serova NK; Aronov MS; Kobiakov GL
Vestn Oftalmol; 2008; 124(1):14-9. PubMed ID: 18318202
[TBL] [Abstract][Full Text] [Related]
18. Intraocular T-cell lymphoma due to mycosis fungoides and response to intravitreal methotrexate.
Reddy R; Kim SJ
Ocul Immunol Inflamm; 2011 Aug; 19(4):234-6. PubMed ID: 21770799
[TBL] [Abstract][Full Text] [Related]
19. Concurrent administration of intravenous systemic and intravitreal methotrexate for intraocular lymphoma with central nervous system involvement.
Nakauchi Y; Takase H; Sugita S; Mochizuki M; Shibata S; Ishiwata Y; Shibuya Y; Yasuhara M; Miura O; Arai A
Int J Hematol; 2010 Jul; 92(1):179-85. PubMed ID: 20464643
[TBL] [Abstract][Full Text] [Related]
20. Intraocular lymphoma: update on diagnosis and management.
Chan CC; Wallace DJ
Cancer Control; 2004; 11(5):285-95. PubMed ID: 15377987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]